Status:
ACTIVE_NOT_RECRUITING
Clinical Reporting to Alleviate the Nocebo Effect
Lead Sponsor:
University of Alabama at Birmingham
Collaborating Sponsors:
American Roentgen Ray Society
Conditions:
Nocebo Effect
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Terminology in radiology reports may cause patients harm by anchoring to or justifying a particular diagnosis. This phenomenon is known as the nocebo effect. MRI may cause patients to pursue more inva...
Eligibility Criteria
Inclusion
- History of lower back pain undergoing MRI
- Greater than 18 years of age
- Able to understand and willing to comply with all study procedures and is available for the duration of the study
Exclusion
- A potential subject who meets any of the following criteria will be excluded from participation in the study:
- Acute lower back pain secondary to trauma within 1 months
- Severe cord compression on MRI
- Cord signal abnormality on MRI
- Metastatic cancer
- Spinal epidural abscess
- Vertebral osteomyelitis
- Judgement of the ordering physician (e.g. focal neurologic deficit)
- Anything that, in the opinion of the investigator or team, would place the subject at increased risk or preclude the subject's full compliance with or completion of the study
Key Trial Info
Start Date :
January 14 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 20 2027
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06103474
Start Date
January 14 2024
End Date
February 20 2027
Last Update
January 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UAB
Birmingham, Alabama, United States, 35294